Bioactivity | Prorenoate potassium is an orally active antihypertensive steroid and an analogue of spironolactone. Prorenoate potassium can be used for hypertensive disease research[1]. |
In Vivo | Prorenoate potassium (10, 30, 100 mg/kg/天, 口服 13 周) 引起剂量相关的促甲状腺激素 (TSH) 水平增加和肝脏重量增加[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
CAS | 49847-97-4 |
Formula | C23H31KO4 |
Molar Mass | 410.59 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Lumb GD, et al. The pathologic response of the liver and thyroid of the rat to potassium prorenoate (SC-23992). Toxicol Pathol. 1985;13(4):315-24. |